$SHMP
NaturalShrimp Inc Stock $shmp

$shmp Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000165495421012150 Filed on November 15, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$16.64K	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.926M	$2.183M	$816.7K
YoY Change	250.78%	167.29%	107.58%
% of Gross Profit
Research & Development	$20.36K	$196.9K	$79.55K
YoY Change		147.48%
% of Gross Profit
Depreciation & Amortization	$218.1K	$404.3K	$8.900K
YoY Change	1100.32%	4442.47%	-33.18%
% of Gross Profit
Operating Expenses	$2.532M	$2.784M	$557.7K
YoY Change	346.36%	399.15%	37.13%
Operating Profit	-$2.516M	-$2.784M	-$557.7K
YoY Change	343.43%	399.15%
Interest Expense	$80.99K	$65.66K	$29.49K
YoY Change	90.38%	122.66%	-106.55%
% of Operating Profit
Other Income/Expense, Net	-$30.85M	-$65.66K	-$32.13K
YoY Change	72420.61%	104.35%
Pretax Income	-$33.37M	-$2.850M	-$589.9K
YoY Change	5371.38%	383.09%	-31.15%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$33.37M	-$2.850M	-$588.2K
YoY Change	5381.03%	384.47%	-31.34%
Net Earnings / Revenue	-200520.1%
Basic Earnings Per Share	-$0.05	$0.00
Diluted Earnings Per Share	-$52.50K	-$4.720K	-$2.447K
COMMON SHARES
Basic Shares Outstanding	636.5M shares	603.0M shares
Diluted Shares Outstanding	635.5M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.665M	$800.5K	$315.6K
YoY Change	754.64%	153.65%	11.42%
Cash & Equivalents	$2.665M	$800.5K	$315.6K
Short-Term Investments
Other Short-Term Assets	$5.327M	$287.1K	$154.1K
YoY Change	584.62%	86.26%	42.56%
Inventory	$28.13K
Prepaid Expenses	$326.5K	$287.1K
Receivables
Other Receivables
Total Short-Term Assets	$8.020M	$1.088M	$469.7K
YoY Change	635.85%	131.54%	18.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.77M	$12.27M	$3.602M
YoY Change	-3.61%	240.63%	41.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$19.88M	$21.13M	$20.63K
YoY Change	96251.67%	102314.0%	0.0%
Total Long-Term Assets	$33.64M	$33.40M	$3.623M
YoY Change	135.23%	821.89%	40.99%
TOTAL ASSETS
Total Short-Term Assets	$8.020M	$1.088M	$469.7K
Total Long-Term Assets	$33.64M	$33.40M	$3.623M
Total Assets	$41.66M	$34.49M	$4.093M
YoY Change	170.68%	742.65%	37.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.321M	$3.822M	$809.6K
YoY Change	270.51%	372.02%	26.58%
Accrued Expenses	$500.5K	$544.0K	$549.1K
YoY Change	-42.34%	-0.94%	-46.4%
Deferred Revenue
YoY Change
Short-Term Debt	$515.5K	$515.5K	$1.825M
YoY Change	-71.73%	-71.76%	-6.73%
Long-Term Debt Due	$96.00K	$106.4K	$279.6K
YoY Change	-14.01%	-61.96%	-73.35%
Total Short-Term Liabilities	$24.35M	$6.208M	$3.558M
YoY Change	527.36%	74.49%	-28.26%
LONG-TERM LIABILITIES
Long-Term Debt	$483.6K	$5.368M	$474.1K
YoY Change	-91.12%	1032.22%
Other Long-Term Liabilities	$303.9K	$321.3K	$275.4K
YoY Change	10.36%	16.68%	4.38%
Total Long-Term Liabilities	$787.5K	$5.689M	$749.5K
YoY Change	-86.24%	659.07%	184.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.35M	$6.208M	$3.558M
Total Long-Term Liabilities	$787.5K	$5.689M	$749.5K
Total Liabilities	$25.14M	$11.90M	$4.222M
YoY Change	164.12%	181.81%	-19.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$101.8M	-$67.41M
YoY Change
Common Stock	$64.18K	$60.68K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.60M	$19.21M	-$215.0K
YoY Change
Total Liabilities & Shareholders Equity	$41.66M	$34.49M	$4.093M
YoY Change	170.68%	742.65%	37.95%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$33.37M	-$2.850M	-$588.2K
YoY Change	5381.03%	384.47%	-31.34%
Depreciation, Depletion And Amortization	$218.1K	$404.3K	$8.900K
YoY Change	1100.32%	4442.47%	-33.18%
Cash From Operating Activities	-$8.048M	-$2.013M	$335.9K
YoY Change	4849.02%	-699.12%	-165.7%
INVESTING ACTIVITIES
Capital Expenditures	-$606.0K	-$782.6K	-$2.355M
YoY Change	-89.11%	-66.77%	415.43%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$2.350M	$0.00
YoY Change
Cash From Investing Activities	-$606.0K	-$3.133M	-$2.355M
YoY Change	-89.11%	33.02%	415.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.52M	-26.86K	1.222M
YoY Change	83.83%	-102.2%	215.32%
NET CHANGE
Cash From Operating Activities	-8.048M	-2.013M	335.9K
Cash From Investing Activities	-606.0K	-3.133M	-2.355M
Cash From Financing Activities	10.52M	-26.86K	1.222M
Net Change In Cash	1.865M	-5.172M	-797.1K
YoY Change	-49692.29%	548.85%	37.26%
FREE CASH FLOW
Cash From Operating Activities	-$8.048M	-$2.013M	$335.9K
Capital Expenditures	-$606.0K	-$782.6K	-$2.355M
Free Cash Flow	-$7.442M	-$1.230M	$2.691M
YoY Change	-237.8%	-145.71%	-5042.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	636528901	shares
CY2021Q3	us-gaap	Cash Cash	800531	USD
CY2021Q1	us-gaap	Cash Cash	155795	USD
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	287068	USD
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	655339	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	1087599	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	811134	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12269987	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12236557	USD
CY2021Q3	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	3171038	USD
CY2021Q1	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	1873219	USD
CY2021Q3	shmp	Patents Patents	6853500	USD
CY2021Q1	shmp	Patents Patents	0	USD
CY2021Q3	shmp	License Agreement LicenseAgreement	10762376	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	320461	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	shmp	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci	1000000	USD
	shmp	Cash Paid For Acquisition Of Shares Of Nci CashPaidForAcquisitionOfSharesOfNci	0	USD
	shmp	Cash Paid For License Agreement CashPaidForLicenseAgreement	2350000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	275400	USD
CY2021Q3	us-gaap	Deposits Assets DepositsAssets	20633	USD
CY2021Q1	us-gaap	Deposits Assets DepositsAssets	20633	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21128008	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2169252	USD
CY2021Q3	us-gaap	Assets Assets	34485594	USD
CY2021Q1	us-gaap	Assets Assets	15216943	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3821506	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	963289	USD
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	73350	USD
CY2021Q1	us-gaap	Interest Payable Current InterestPayableCurrent	73350	USD
CY2021Q3	shmp	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	187520	USD
CY2021Q1	shmp	Related Parties Interest Payable Current RelatedPartiesInterestPayableCurrent	187520	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	543972	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	602368	USD
CY2021Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	600000	USD
CY2021Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	0	USD
CY2021Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	20044	USD
CY2021Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	573621	USD
CY2021Q3	us-gaap	Loans Payable To Bank LoansPayableToBank	10380	USD
CY2021Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	8725	USD
CY2021Q3	us-gaap	Loans Payable Current LoansPayableCurrent	0	USD
CY2021Q1	us-gaap	Loans Payable Current LoansPayableCurrent	103200	USD
CY2021Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2021Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	483637	USD
CY2021Q3	us-gaap	Notes Payable Current NotesPayableCurrent	96000	USD
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	96000	USD
CY2021Q3	shmp	Notes Payable Related Parties NotesPayableRelatedParties	495412	USD
CY2021Q1	shmp	Notes Payable Related Parties NotesPayableRelatedParties	1151162	USD
CY2021Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	360226	USD
CY2021Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	182639	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6208410	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4425511	USD
CY2021Q3	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	200358	USD
CY2021Q1	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	206127	USD
CY2021Q3	us-gaap	Notes Payable NotesPayable	5000000	USD
CY2021Q1	us-gaap	Notes Payable NotesPayable	5000000	USD
CY2021Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	167604	USD
CY2021Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	215604	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	321336	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	275400	USD
CY2021Q3	us-gaap	Liabilities Liabilities	11897708	USD
CY2021Q1	us-gaap	Liabilities Liabilities	10122642	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	607134014	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	560745180	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	606821513	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	560745180	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	60683	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	56075	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	74609294	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56649491	USD
CY2021Q3	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	11948176	USD
	shmp	Net Loss Available For Common Stockholders NetLossAvailableForCommonStockholders	12023000	USD
CY2021Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	136000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67408142	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53683268	USD
CY2021Q3	shmp	Total Stockholders Deficit Attributable To Naturalshrimp Incorporated Shareholders TotalStockholdersDeficitAttributableToNaturalshrimpIncorporatedShareholders	19210511	USD
CY2021Q1	shmp	Total Stockholders Deficit Attributable To Naturalshrimp Incorporated Shareholders TotalStockholdersDeficitAttributableToNaturalshrimpIncorporatedShareholders	3158798	USD
CY2021Q3	us-gaap	Members Equity Attributable To Noncontrolling Interest MembersEquityAttributableToNoncontrollingInterest	0	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19677	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2783972	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	557746	USD
	us-gaap	Operating Expenses OperatingExpenses	5022062	USD
	us-gaap	Operating Expenses OperatingExpenses	915878	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2783972	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-557746	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5022062	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-915878	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	65663	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	29490	USD
CY2021Q1	us-gaap	Members Equity Attributable To Noncontrolling Interest MembersEquityAttributableToNoncontrollingInterest	-87830	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19210511	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3070968	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34485594	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15216943	USD
CY2021Q3	us-gaap	Revenues Revenues	0	USD
CY2020Q3	us-gaap	Revenues Revenues	0	USD
	us-gaap	Revenues Revenues	0	USD
	us-gaap	Revenues Revenues	0	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2010397	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	401029	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3654659	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	737008	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	196872	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	79550	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	196872	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	79550	USD
CY2021Q3	us-gaap	Facility Costs FacilityCosts	172431	USD
CY2020Q3	us-gaap	Facility Costs FacilityCosts	68271	USD
	us-gaap	Facility Costs FacilityCosts	411756	USD
	us-gaap	Facility Costs FacilityCosts	79643	USD
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	404272	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8896	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	758775	USD
	us-gaap	Interest Expense InterestExpense	147199	USD
	us-gaap	Interest Expense InterestExpense	59516	USD
CY2021Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2020Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	236364	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021Q3	shmp	Financing Costs FinancingCosts	0	USD
CY2020Q3	shmp	Financing Costs FinancingCosts	-2643	USD
	shmp	Financing Costs FinancingCosts	-109953	USD
	shmp	Financing Costs FinancingCosts	-64452	USD
CY2021Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-29000	USD
CY2021Q3	shmp	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	0	USD
	shmp	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	103200	USD
	shmp	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	0	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-65663	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-32133	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-390316	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-152968	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2849635	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-589879	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5412378	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1068846	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-2849635	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-589879	USD
	us-gaap	Profit Loss ProfitLoss	-5412378	USD
	us-gaap	Profit Loss ProfitLoss	-1068846	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1686	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3581	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2849635	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-588193	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5412378	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1065265	USD
CY2021Q3	shmp	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	0	USD
CY2020Q3	shmp	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-807000	USD
	shmp	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-817376	USD
	shmp	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-1100000	USD
CY2020Q3	shmp	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares	0	USD
	shmp	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares	-5792947	USD
	shmp	Redemption And Exchange Of Series D Preferred Shares RedemptionAndExchangeOfSeriesDPreferredShares	0	USD
CY2021Q3	us-gaap	Dividends Dividends	0	USD
CY2020Q3	us-gaap	Dividends Dividends	83960	USD
	us-gaap	Dividends Dividends	0	USD
	us-gaap	Dividends Dividends	228752	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2849635	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1479153	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12022701	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2394017	USD
CY2021Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2021Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	603775024	shares
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	451549772	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	594359747	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	419177832	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	3070969	USD
CY2021Q2	shmp	Issuance Of Common Share Upon Conversion Amount IssuanceOfCommonShareUponConversionAmount	421486	USD
CY2021Q2	shmp	Conversion Of Series B Ps To Common Stock Amount ConversionOfSeriesBPsToCommonStockAmount	0	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	USD
CY2021Q2	shmp	Exchange Of Series D Ps To Series E Ps ExchangeOfSeriesDPsToSeriesEPs	-3258189	USD
CY2021Q2	shmp	Sale Of Common Shares And Warrants For Cash Less Offering Costs And Commitment Shares Amount SaleOfCommonSharesAndWarrantsForCashLessOfferingCostsAndCommitmentSharesAmount	17277123	USD
CY2021Q2	shmp	Exercise Of Warrants Related To The Sale Of Common Shares Amount ExerciseOfWarrantsRelatedToTheSaleOfCommonSharesAmount	11000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3269505	USD
CY2021Q2	shmp	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-817376	USD
CY2021Q2	shmp	Redemption Of Series D Preferred Shares RedemptionOfSeriesDPreferredShares	-2534758	USD
CY2021Q2	shmp	Common Shares To Be Issued For The Acquisition Of The Non Controlling Interest Subsidiarys Remaining Equity CommonSharesToBeIssuedForTheAcquisitionOfTheNonControllingInterestSubsidiarysRemainingEquity	-1000000	USD
CY2021Q2	shmp	Common Shares To Be Issued For Patent Acquisition CommonSharesToBeIssuedForPatentAcquisition	5000000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	73651	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2562743	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	18950668	USD
CY2021Q3	shmp	Conversion Of Series E Ps To Common Stock Amount ConversionOfSeriesEPsToCommonStockAmount	0	USD
CY2020Q3	shmp	Conversion Of Series B Ps To Common Stock Amount ConversionOfSeriesBPsToCommonStockAmount	0	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	61250	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-478967	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-1062394	USD
CY2020Q3	shmp	Issuance Of Common Share Upon Conversion Amount IssuanceOfCommonShareUponConversionAmount	125736	USD
CY2020Q3	shmp	Series B Preferred Stock Issued During Period Value New Issues SeriesBPreferredStockIssuedDuringPeriodValueNewIssues	1250000	USD
CY2020Q3	shmp	Beneficial Conversion Feature Related To The Series B Preferred Shares BeneficialConversionFeatureRelatedToTheSeriesBPreferredShares	0	USD
CY2020Q3	shmp	Dividends Payable On Series B Ps DividendsPayableOnSeriesBPs	-83960	USD
CY2020Q3	shmp	Series B Ps Dividends In Kind Issued Amount SeriesBPsDividendsInKindIssuedAmount	77984	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	67500	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-215012	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5412378	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1065265	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	758775	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19677	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	236364	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2021Q3	shmp	Amortization Of Beneficial Conversion Feature Related To Series E Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToSeriesEPreferredShares	-1341948	USD
CY2021Q3	shmp	Common Shares To Be Issued For Technical And Equipment Rights Agreement CommonSharesToBeIssuedForTechnicalAndEquipmentRightsAgreement	4762376	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	49275	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-2849635	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	19210511	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-2937780	USD
CY2020Q2	shmp	Issuance Of Common Share Upon Conversion Amount IssuanceOfCommonShareUponConversionAmount	226437	USD
CY2020Q2	us-gaap	Prior Period Reclassification Adjustment PriorPeriodReclassificationAdjustment	205000	USD
CY2020Q2	shmp	Series B Preferred Stock Issued During Period Value New Issues SeriesBPreferredStockIssuedDuringPeriodValueNewIssues	1250000	USD
CY2020Q2	shmp	Beneficial Conversion Feature Related To The Series B Preferred Shares BeneficialConversionFeatureRelatedToTheSeriesBPreferredShares	0	USD
CY2020Q2	shmp	Dividends Payable On Series B Ps DividendsPayableOnSeriesBPs	-144792	USD
CY2020Q2	shmp	Series B Ps Dividends In Kind Issued Amount SeriesBPsDividendsInKindIssuedAmount	56458	USD
CY2020Q2	shmp	Conversion Of Series B Ps To Common Stock Amount ConversionOfSeriesBPsToCommonStockAmount	0	USD
CY2020Q2	shmp	Common Stock Issued In Vista Warrant Settlement Amount CommonStockIssuedInVistaWarrantSettlementAmount	610000	USD
CY2020Q2	shmp	Prior Period Reclassification Adjustment Other PriorPeriodReclassificationAdjustmentOther	90000	USD
	shmp	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	0	USD
	shmp	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	29000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	109953	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
	shmp	Default Penalty DefaultPenalty	41112	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3581	USD
	shmp	Forgiveness Of Pp Loan ForgivenessOfPpLoan	-103200	USD
	shmp	Forgiveness Of Pp Loan ForgivenessOfPpLoan	0	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	122926	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	128750	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-281729	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-25424	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-138766	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	168448	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-58396	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-174926	USD
	shmp	Accrued Expenses Related Parties AccruedExpensesRelatedParties	600000	USD
	shmp	Accrued Expenses Related Parties AccruedExpensesRelatedParties	0	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	13018	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	13000	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	0	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	18096	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4153434	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	168000	USD
CY2021Q3	shmp	Working Capital Deficit WorkingCapitalDeficit	5119000	USD
	shmp	Proceeds From Issuance Of Common Shares Under Equity Agreement ProceedsFromIssuanceOfCommonSharesUnderEquityAgreement	17277000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	10000000	shares
CY2020Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1560000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-851113	USD
CY2021Q2	shmp	Ownership Subsidiary OwnershipSubsidiary	100
	us-gaap	Debt Instrument Convertible Associated Derivative Transactions Description DebtInstrumentConvertibleAssociatedDerivativeTransactionsDescription	conversion prices ranging from $0.124 to $0.25 for fixed conversion rates which were not included in the calculation of diluted EPS as their effect would be anti-dilutive
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	421486	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	645705	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	742388	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2000000	USD
	shmp	Cash Paid For License Agreement CashPaidForLicenseAgreement	0	USD
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13471915	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12891078	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1201928	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12269987	USD
CY2020Q3	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	9000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	661000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	20000	USD
CY2018Q1	shmp	Partnership Prcentage PartnershipPrcentage	100
CY2021Q3	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	1	pure
	shmp	Agreements Term AgreementsTerm	P10Y
	shmp	Consideration For The Equipment Rights ConsiderationForTheEquipmentRights	2500000	USD
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	500000	USD
	shmp	Consideration For The Equipment Rights Paid Next Quarter ConsiderationForTheEquipmentRightsPaidNextQuarter	500000	USD
CY2021Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	250000	USD
CY2021Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	375000	USD
CY2021Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	625000	USD
CY2021Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears	875000	USD
CY2021Q3	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	1000000	USD
CY2020Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	103200	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	103200	USD
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	17277123	USD
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	0	USD
	shmp	Shares Issued Upon Exercise Of Warrants SharesIssuedUponExerciseOfWarrants	11000	USD
	shmp	Shares Issued Upon Exercise Of Warrants SharesIssuedUponExerciseOfWarrants	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	2500000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	shmp	Redemption Of Series D Ps RedemptionOfSeriesDPs	-3513504	USD
	shmp	Redemption Of Series D Ps RedemptionOfSeriesDPs	0	USD
	shmp	Cash Received From Warrant Settlement CashReceivedFromWarrantSettlement	0	USD
	shmp	Cash Received From Warrant Settlement CashReceivedFromWarrantSettlement	50000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12091692	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2621062	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	644736	USD
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	917210	USD
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	1297819	USD
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	1738661	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7293524	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1563839	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	4114	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	15794	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	48000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	24000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	655750	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
	shmp	Repayment Of Short Term Promissory Note And Lines Of Credit RepaymentOfShortTermPromissoryNoteAndLinesOfCredit	553577	USD
	shmp	Repayment Of Short Term Promissory Note And Lines Of Credit RepaymentOfShortTermPromissoryNoteAndLinesOfCredit	-7656	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	206110	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	155795	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109491	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	800531	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	315601	USD
	us-gaap	Interest Paid Net InterestPaidNet	147199	USD
	us-gaap	Interest Paid Net InterestPaidNet	41420	USD
	shmp	Shares Issued Upon Conversion SharesIssuedUponConversion	421486	USD
	shmp	Shares Issued Upon Conversion SharesIssuedUponConversion	336437	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	275400	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	0	USD
	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	134443	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	610000	USD
	shmp	Shares To Be Issued As Consideration For Patent Acquisition SharesToBeIssuedAsConsiderationForPatentAcquisition	5000000	USD
	shmp	Shares To Be Issued As Consideration For Patent Acquisition SharesToBeIssuedAsConsiderationForPatentAcquisition	0	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2000000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	0	USD
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	383604	USD
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – NATURE OF THE ORGANIZATION AND BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Nature of the Business</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">NaturalShrimp Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a biotechnology company and has developed a proprietary technology that allows it to grow Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density, low-cost environment, and in fully contained and independent production facilities. The Company’s system uses technology which allows it to produce a naturally-grown shrimp “crop” weekly and accomplishes this without the use of antibiotics or toxic chemicals. The Company has developed several proprietary technology assets, including a knowledge base that allows it to produce commercial quantities of shrimp in a closed system with a computer monitoring system that automates, monitors and maintains proper levels of oxygen, salinity and temperature for optimal shrimp production. The Company’s production facilities are located in La Coste, Texas and Webster City, Iowa.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">On December 15, 2020, the Company entered into an Asset Purchase Agreement (“APA”) between VeroBlue Farms USA, Inc., a Nevada corporation (“VBF”), VBF Transport, Inc., a Delaware corporation (“Transport”), and Iowa’s First, Inc., an Iowa corporation (“Iowa’s First”) (each a “Seller” and collectively, “Sellers”). Transport and Iowa’s First were wholly-owned subsidiaries of VBF. The agreement called for the Company to purchase all of the tangible assets of VBF, the motor vehicles of Transport and the real property (together with all plants, buildings, structures, fixtures, fittings, systems and other improvements located on such real property) of Iowa’s First. The facility was originally designed as an aquaculture facility, with the company having production issues. The Company began a modification process to convert the plant to produce shrimp, which will allow them to scale faster without having to build new facilities. The three Iowa facilities contain the tanks and infrastructure that will be used to support the production of shrimp with the incorporation of the Company's patented EC platform technology. On May 19, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with F&T Water Solutions, LLC (“F&T”), for F&T’s owned shares of Natural Aquatic Systems, Inc. (“NAS”). Prior to entering into the SPA, the Company owned fifty-one percent (51%) and F&T owned forty-nine percent (49%) of the issued and outstanding shares of common stock of NAS. After the SPA, NAS is a 100% owned subsidiary of the Company (See Note 8).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company has three wholly-owned subsidiaries including NaturalShrimp USA Corporation, NaturalShrimp Global, Inc. and NAS.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Going Concern</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the six months ended September 30, 2021, the Company had a net loss available for common stockholders of approximately $12,023,000. At September 30, 2021, the Company had an accumulated deficit of approximately $67,408,000 and a working capital deficit of approximately $5,119,000. These factors raise substantial doubt about the Company’s ability to continue as a going concern, within one year from the issuance date of this filing. The Company’s ability to continue as a going concern is dependent on its ability to raise the required additional capital or debt financing to meet short and long-term operating requirements. During the six months ended September 30, 2021, the Company received net cash proceeds of approximately $17,277,000 from the sale of common shares (See Note 11). Management believes that private placements of equity capital will be needed to fund the Company’s long-term operating requirements. The Company may also encounter business endeavors that require significant cash commitments or unanticipated problems or expenses that could result in a requirement for additional cash. If the Company raises additional funds through the issuance of equity, the percentage ownership of its current shareholders could be reduced, and such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict our operations. The Company continues to pursue external financing alternatives to improve its working capital position. If the Company is unable to obtain the necessary capital, the Company may be unable to develop its facilities and enter in production.</p>
CY2021Q3	shmp	Accumulated Deficit AccumulatedDeficit	67408000	USD
CY2021Q1	shmp	Original Discount OriginalDiscount	120000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.12	pure
CY2021Q1	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	0.36
CY2021Q1	shmp	Change In Conversion Rate ChangeInConversionRate	0.10
CY2021Q1	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	164000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	27273	USD
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	20000	USD
CY2021Q2	us-gaap	Repayments Of Subordinated Debt RepaymentsOfSubordinatedDebt	720000	USD
CY2021Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	13000	USD
CY2021Q2	us-gaap	Redemption Premium RedemptionPremium	110000	USD
CY2021	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	3124	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	10380	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	20760	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	20760	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	20760	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	20760	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	117318	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	210738	USD
CY2021Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	720000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13861386	USD
CY2021Q3	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	300000	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	USD
CY2021Q2	us-gaap	Defined Benefit Plan Settlements Benefit Obligation DefinedBenefitPlanSettlementsBenefitObligation	421486	USD
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1303982	shares
CY2021Q2	shmp	Reedemable Options Percentage ReedemableOptionsPercentage	1.15	pure
CY2021Q2	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	3144000	shares
CY2021Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	15000	USD
CY2021Q1	shmp	Prepaid Expense Remaining Balance PrepaidExpenseRemainingBalance	308250	USD
CY2021	us-gaap	Legal Fees LegalFees	308250	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	114000	USD
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	154000	USD
	shmp	Consulting Services ConsultingServices	50000	USD
CY2016Q1	shmp	Additional Borrowed Amount AdditionalBorrowedAmount	134750	USD
	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	77000	USD
CY2021	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	735000	USD
CY2021Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	132000	USD
CY2021Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	290000	USD
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2021Q2	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	842972	USD
CY2021Q2	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	300000	USD
CY2017Q1	shmp	Additional Borrowed Amount AdditionalBorrowedAmount	601361	USD
CY2021Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	118000	USD
CY2019Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	5000	USD
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	USD
CY2021Q2	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
CY2021Q2	us-gaap	Operating Leases Rent Expense Minimum Rentals OperatingLeasesRentExpenseMinimumRentals	1727	USD
CY2021Q2	us-gaap	Deposits Deposits	52362	USD
CY2021Q2	us-gaap	Security Deposit SecurityDeposit	17454	USD
CY2021Q2	us-gaap	Operations Commenced Date1 OperationsCommencedDate1	2021-08-01
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	316000	USD
CY2021Q3	shmp	Borrowing Rate BorrowingRate	5.75
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	300	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	USD
CY2021Q3	shmp	Borrowing Rate BorrowingRate	5.75
CY2019Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	275400	USD
CY2019Q2	shmp	Borrowing Rate BorrowingRate	5
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9842000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company maintains cash balances at two financial institutions. Accounts at this institution are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. As of September 30, 2021 the Company’s cash balance exceeded FDIC coverage. As of March 31, 2021, the Company’s cash balance did not exceed FDIC coverage. The Company has not experienced any losses in such accounts and periodically evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.</p>
CY2021Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2021Q3	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	307000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	250000	USD
	shmp	Royalty Fees Percentage RoyaltyFeesPercentage	12.5
	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	The note was paid off in full in July of 2021.
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2021Q3	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.0001
	us-gaap	Legal Fees LegalFees	308250	USD
CY2021Q3	shmp	Consulting Services ConsultingServices	655750	USD
CY2021Q3	shmp	Litigation Settlement Amount LitigationSettlementAmount	8000	USD

Files In Submission

Name	View Source	Status
0001654954-21-012150-index-headers.html	Edgar Link	pending
0001654954-21-012150-index.html	Edgar Link	pending
0001654954-21-012150.txt	Edgar Link	pending
0001654954-21-012150-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shmp-20210930.xsd	Edgar Link	pending
shmp-20210930_cal.xml	Edgar Link	unprocessable
shmp-20210930_def.xml	Edgar Link	unprocessable
shmp-20210930_lab.xml	Edgar Link	unprocessable
shmp-20210930_pre.xml	Edgar Link	unprocessable
shmp_10q.htm	Edgar Link	pending
shmp_10q_htm.xml	Edgar Link	completed
shmp_ex311.htm	Edgar Link	pending
shmp_ex312.htm	Edgar Link	pending
shmp_ex321.htm	Edgar Link	pending
shmp_ex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHMP
NaturalShrimp Inc Stock $shmp

2021 Q4 Form 10-Q Financial Statement

#000165495421012150 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP NaturalShrimp Inc Stock $shmp

2021 Q4 Form 10-Q Financial Statement

#000165495421012150 Filed on November 15, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP
NaturalShrimp Inc Stock $shmp